I have been involved in research for about a decade now, from my undergraduate program through to my PhD training. Over this period of time, I have learned the skills and ethics needed to be successful as an independent researcher. In the earlier part of my career, I studied the pharmacology of natural drug products. Use of medicinal plant is common in local Ghanaian communities, even though beneficial effects have not been proven scientifically. I studied the effects of the extracts of two such plants, Piper guineense and Antrocaryon micraster using validated animal models of disease states.
My PhD dissertation research is focused on Leptin Signaling in Glial fibrillary acidic protein (GFAP) – Interferon Alpha (GIFN) transgenic mice. This project involves investigating the molecular mechanisms involved in leptin resistance and its implication in the management of obesity. Outside of my bench research work, I am collaborating with a clinical veterinary researcher, Dr Emma Meyer in two ongoing research in Veterinary Medicine Error Report and Pharmacokinetic Studies of Nitrofurantoin in dogs.
I have been trained in research ethics, mouse handling techniques, behavior assays, analytical laboratory techniques such as western blot, pcr and flow cytometery. I have gained translational research skills through the collaboration with a clinical faculty. All of these trainings and skills have given me the competency to succeed in a career as an independent researcher in understanding immunological disease mechanisms to identify points of therapeutic control.
<script src="https://platform.linkedin.com/badges/js/profile.js" async defer type="text/javascript"></script>
<div class="badge-base LI-profile-badge" data-locale="en_US" data-size="medium" data-theme="dark" data-type="VERTICAL" data-vanity="leslie-essel-363062100" data-version="v1"><a class="badge-base__link LI-simple-link" href="https://www.linkedin.com/in/leslie-essel-363062100?trk=profile-badge">Leslie Essel</a></div>
Essel, L. B., Obiri, D. D., Osafo, N., Antwi, A. O., Duduyemi, B. D. (July, 2017). The total ethanolic stem bark extract of Antrocaryon micraster ameliorates acetic acid-induced colitis through reduced serum levels of TNFα and IL-6. Poster presented at the 2017 annual meeting of the Ghana Biomedical Convention Conference, Accra, Ghana
Essel, L. B., Obiri, D. D., Osafo, N., Antwi, A. O., Duduyemi, B. D. (March, 2017). Anti-inflammatory and anti-oxidant effects of the ethanolic stem-bark extract of Antrocaryon micraster (Anacardiaceae) A. Chev. & Guillaumin. in murine models of inflammation. Poster presented at the Building Stronger Universities (BSU II) Phase 2 Conference, (A collaboration between the Royal Danish Government, Danish Universities and KNUST, Kumasi, Ghana.
Essel, L. B. (March, 2017). Anti-inflammatory and anti-oxidant effects of the ethanolic stem-bark extract of Antrocaryon micraster (Anacardiaceae) A. Chev. & Guillaumin. in murine models of inflammation. Paper presented at the Graduate Students’ conference, School of Pharmacy and Pharmaceutical Sciences, KNUST, Kumasi, Ghana.
Theses an Dissertations
Essel, L., B. (2016). Anti-inflammatory and anti-oxidant effects of the ethanolic stem-bark extract of Antrocaryon micraster (Anacardiaceae) A. Chev. & Guillaumin in murine models of inflammation. Masters Thesis. School of Grduate Studies, Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, Ghana
Essel, L., B. (2013). Anti-inflammatory activity of Piper guineense (Piperaceae). Bachelor’s Thesis. School ofPharmacy and Pharmaceutical Sciences, Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, Ghana
Journal Articles
Melia McDaniel, Elly Glazier, NiNi Truong, Leslie Marsh, Noah Cahill, Leslie Brian Essel, Brittany L. Melton, Emma G. Meyer, Veterinary prescription errors in a community pharmacy setting: A retrospective review, Journal of the American Pharmacists Association, Volume 62, Issue 2, 2022, Pages 512-518, ISSN 1544-3191, https://doi.org/10.1016/j.japh.2021.11.007. (https://www.sciencedirect.com/science/article/pii/S1544319121004684
Essel, L., Obiri, D., Osafo, N., Antwi, A., & Duduyemi, M. (2020). Ulcerative colitis induced with acetic acid is ameliorated by Antrocaryon micraster through reduced serum levels of tumor necrosis factor alpha and interleukin-6 in sprague dawley rats. Pharmacognosy Research, 12(1), 85-91. https://doi.org/10.4103/pr.pr_75_19
Aidoo, D. B., Obiri, D. D., Osafo, N., Antwi, A. O., Essel, L. B., Duduyemi, B. M., & Ekor, M. (2019). Allergic airway-induced hypersensitivity is attenuated by bergapten in murine models of inflammation. Advances in pharmacological sciences, 2019. https://doi.org/10.1155/2019/6097349
Osafo, N., Obiri, D.D., Danquah, K.O., Essel, L.B. and Antwi, A.O., 2019. Potential effects of xylopic acid on acetic acid-induced ulcerative colitis in rats. The Turkish Journal of Gastroenterology, 30(8), p.732. https://doi.org/10.5152/tjg.2019.18389
Antwi, A. O., Obiri, D. D., Osafo, N., Essel, L. B., Forkuo, A. D., & Atobiga, C. (2018). Stigmasterol alleviates cutaneous allergic responses in rodents. BioMed research international, 2018. https://doi.org/10.1155/2018/3984068
Osafo, N., Obiri, D.D., Danquah, K.O., Essel, L.B. and Antwi, A.O., 2018. Effect of xylopic acid isolated from Xylopia aethiopica on acetic acid‐induced ulcerative colitis in rats. The FASEB Journal, 32, pp.702-8. https://doi.org/10.1096/fasebj.2018.32.1_supplement.702.8
Essel, L. B., Obiri, D. D., Osafo, N., Antwi, A. O., & Duduyemi, B. M. (2017). The ethanolic stem-bark extract of Antrocaryon micraster inhibits carrageenan-induced pleurisy and pedal oedema in murine models of inflammation. International scholarly research notices, 2017. https://doi.org/10.1155/2017/6859230
Antwi, A. O., Obiri, D. D., Osafo, N., Forkuo, A. D., & Essel, L. B. (2017). Stigmasterol inhibits lipopolysaccharide-induced innate immune responses in murine models. International Immunopharmacology, 53, 105-113. https://doi.org/10.1016/j.intimp.2017.10.018
Book Chapters
Osafo, N., Obeng, S., Obiri, D.D., Yeboah, O.K., & Essel L. B. (2020). Pharmacological Management of Alzheimer’s Disease. In Sahab Uddin, M., & Rashid, M. Eds., Advances in Neuropharmacology. (pp. 151-174) New York: Apple Academic Press. https://doi.org/10.1201/9780429242717
2020-2021 Robert C. Lanman Graduate Pharmacology Scholarship Competitive and Merit-based scholarship award offered by the UMKC School of Pharmacy Foundation.
2019-2020 Preparing Future Faculty (PFF) ScholarAward Fellowship An award to train graduate students in the College Teaching and Career Preparation Certificate Program offered by the School of Graduate Studies / School of Education, UMKC.
2019-2020 Robert C. Lanman Graduate Pharmacology Scholarship Competitive and Merit-based scholarship award offered by the UMKC School of Pharmacy Foundation.
2018-2019 Thomas D. Ross Memorial Graduate Scholarship Competitive and Merit-based scholarship award offered by the UMKC School of Pharmacy Foundation.
UMKC Graduate Scholarship Division of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Missouri – Kansas City (UMKC), Missouri, USA
Graduate Teaching Assistant (2014-2016) Department of Pharmacology, School of Pharmacy, Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, Ghana
Graduate Teaching Assistant (2013-2014) Department of Biomedical and Forensic Sciences, School of Biological Sciences, University of Cape Coast, Cape Coast, Ghana.
Leptin Signaling in Glial fibrillary acidic protein (GFAP) – Interferon Alpha (GIFN) Transgenic mice
My research focuses on cytokine and hormonal signaling pathways in the brain that lead to leptin resistance. The hormone leptin produces anorexic effects and promotes energy metabolism, actions that lead to normal physiological maintenance of a healthy body weight. Failure of leptin’s action, referred to as leptin resistance, leads to hyperphagia, dysregulated energy homeostasis and obesity. Obesity is prevalent in the general population and is a major risk factor of cardiovascular and metabolic disease. A restoration of leptin’s function should mitigate obesity. My research approach is to define the particular pathway of leptin resistance, and thereby identify a target for a therapeutic drug that will disrupt this resistance pathway. My research is very close to defining this pathway, as work progresses steadily. A successful completion of this project will not only provide an insight into novel pathway mechanisms, but it will also have huge clinical implications in the management of obesity. As a risk factor, obesity can lead to the development of heart disease and diabetes, which have high morbidity and mortality rates in American societies. The ability to significantly reduce this high disease burden by being able to effectively deal with the problem of obesity underscores the relevance and impact of this study.